177 related articles for article (PubMed ID: 26029994)
1. Understanding the Mechanism of Enzyme-Induced Formation of Lyotropic Liquid Crystalline Nanoparticles.
Hong L; Salentinig S; Hawley A; Boyd BJ
Langmuir; 2015 Jun; 31(24):6933-41. PubMed ID: 26029994
[TBL] [Abstract][Full Text] [Related]
2. Generation of geometrically ordered lipid-based liquid-crystalline nanoparticles using biologically relevant enzymatic processing.
Fong WK; Salentinig S; Prestidge CA; Mezzenga R; Hawley A; Boyd BJ
Langmuir; 2014 May; 30(19):5373-7. PubMed ID: 24783947
[TBL] [Abstract][Full Text] [Related]
3. Novel steric stabilizers for lyotropic liquid crystalline nanoparticles: PEGylated-phytanyl copolymers.
Chong JY; Mulet X; Keddie DJ; Waddington L; Mudie ST; Boyd BJ; Drummond CJ
Langmuir; 2015 Mar; 31(9):2615-29. PubMed ID: 25068381
[TBL] [Abstract][Full Text] [Related]
4. Disposition and association of the steric stabilizer Pluronic® F127 in lyotropic liquid crystalline nanostructured particle dispersions.
Tilley AJ; Drummond CJ; Boyd BJ
J Colloid Interface Sci; 2013 Feb; 392():288-296. PubMed ID: 23137909
[TBL] [Abstract][Full Text] [Related]
5. Lipid-PEG conjugates sterically stabilize and reduce the toxicity of phytantriol-based lyotropic liquid crystalline nanoparticles.
Zhai J; Hinton TM; Waddington LJ; Fong C; Tran N; Mulet X; Drummond CJ; Muir BW
Langmuir; 2015 Oct; 31(39):10871-80. PubMed ID: 26362479
[TBL] [Abstract][Full Text] [Related]
6. In Vivo Formation of Cubic Phase in Situ after Oral Administration of Cubic Phase Precursor Formulation Provides Long Duration Gastric Retention and Absorption for Poorly Water-Soluble Drugs.
Pham AC; Hong L; Montagnat O; Nowell CJ; Nguyen TH; Boyd BJ
Mol Pharm; 2016 Jan; 13(1):280-6. PubMed ID: 26567591
[TBL] [Abstract][Full Text] [Related]
7. High-throughput discovery of novel steric stabilizers for cubic lyotropic liquid crystal nanoparticle dispersions.
Chong JY; Mulet X; Waddington LJ; Boyd BJ; Drummond CJ
Langmuir; 2012 Jun; 28(25):9223-32. PubMed ID: 22630595
[TBL] [Abstract][Full Text] [Related]
8. Phytantriol based smart nano-carriers for drug delivery applications.
Akbar S; Anwar A; Ayish A; Elliott JM; Squires AM
Eur J Pharm Sci; 2017 Apr; 101():31-42. PubMed ID: 28137471
[TBL] [Abstract][Full Text] [Related]
9. Modulatory effect of human plasma on the internal nanostructure and size characteristics of liquid-crystalline nanocarriers.
Azmi ID; Wu L; Wibroe PP; Nilsson C; Østergaard J; Stürup S; Gammelgaard B; Urtti A; Moghimi SM; Yaghmur A
Langmuir; 2015 May; 31(18):5042-9. PubMed ID: 25884233
[TBL] [Abstract][Full Text] [Related]
10. Size and phase control of cubic lyotropic liquid crystal nanoparticles.
Hartnett TE; Ladewig K; O'Connor AJ; Hartley PG; McLean KM
J Phys Chem B; 2014 Jul; 118(26):7430-9. PubMed ID: 24915497
[TBL] [Abstract][Full Text] [Related]
11. Understanding the interfacial properties of nanostructured liquid crystalline materials for surface-specific delivery applications.
Dong YD; Larson I; Barnes TJ; Prestidge CA; Allen S; Chen X; Roberts CJ; Boyd BJ
Langmuir; 2012 Sep; 28(37):13485-95. PubMed ID: 22889049
[TBL] [Abstract][Full Text] [Related]
12. Revisiting β-casein as a stabilizer for lipid liquid crystalline nanostructured particles.
Zhai J; Waddington L; Wooster TJ; Aguilar MI; Boyd BJ
Langmuir; 2011 Dec; 27(24):14757-66. PubMed ID: 22026367
[TBL] [Abstract][Full Text] [Related]
13. Self-assembled geometric liquid-crystalline nanoparticles imaged in three dimensions: hexosomes are not necessarily flat hexagonal prisms.
Boyd BJ; Rizwan SB; Dong YD; Hook S; Rades T
Langmuir; 2007 Dec; 23(25):12461-4. PubMed ID: 17988167
[TBL] [Abstract][Full Text] [Related]
14. Bulk and dispersed aqueous phase behavior of phytantriol: effect of vitamin E acetate and F127 polymer on liquid crystal nanostructure.
Dong YD; Larson I; Hanley T; Boyd BJ
Langmuir; 2006 Nov; 22(23):9512-8. PubMed ID: 17073473
[TBL] [Abstract][Full Text] [Related]
15. Nanostructured reverse hexagonal liquid crystals sustain plasma concentrations for a poorly water-soluble drug after oral administration.
Nguyen TH; Hanley T; Porter CJ; Boyd BJ
Drug Deliv Transl Res; 2011 Dec; 1(6):429-38. PubMed ID: 25786363
[TBL] [Abstract][Full Text] [Related]
16. Adsorption of nonlamellar nanostructured liquid-crystalline particles to biorelevant surfaces for improved delivery of bioactive compounds.
Dong YD; Larson I; Barnes TJ; Prestidge CA; Boyd BJ
ACS Appl Mater Interfaces; 2011 May; 3(5):1771-80. PubMed ID: 21506614
[TBL] [Abstract][Full Text] [Related]
17. Bulk and dispersed aqueous behaviour of an endogenous lipid, selachyl alcohol: Effect of Tween 80 and Pluronic F127 on nanostructure.
Younus M; Hawley A; Boyd BJ; Rizwan SB
Colloids Surf B Biointerfaces; 2018 Sep; 169():135-142. PubMed ID: 29758539
[TBL] [Abstract][Full Text] [Related]
18. Lyotropic Liquid-Crystalline Nanosystems as Drug Delivery Agents for 5-Fluorouracil: Structure and Cytotoxicity.
Astolfi P; Giorgini E; Gambini V; Rossi B; Vaccari L; Vita F; Francescangeli O; Marchini C; Pisani M
Langmuir; 2017 Oct; 33(43):12369-12378. PubMed ID: 29023126
[TBL] [Abstract][Full Text] [Related]
19. Amphiphilic brush polymers produced using the RAFT polymerisation method stabilise and reduce the cell cytotoxicity of lipid lyotropic liquid crystalline nanoparticles.
Zhai J; Suryadinata R; Luan B; Tran N; Hinton TM; Ratcliffe J; Hao X; Drummond CJ
Faraday Discuss; 2016 Oct; 191():545-563. PubMed ID: 27453499
[TBL] [Abstract][Full Text] [Related]
20. PEGylation of phytantriol-based lyotropic liquid crystalline particles--the effect of lipid composition, PEG chain length, and temperature on the internal nanostructure.
Nilsson C; Østergaard J; Larsen SW; Larsen C; Urtti A; Yaghmur A
Langmuir; 2014 Jun; 30(22):6398-407. PubMed ID: 24833115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
